Search research articles
Contact Us
Filters
Showing results (131-140 of 611) with videos related to
Page
of 62
Sort By:
Neuroscience Letters
|
February 25, 1991
Cholinergic neuronal loss in the globus pallidus of Alzheimer disease patients
S Lehéricy, E C Hirsch, L B Hersh, et al.
Archives of Neurology
|
November 1, 1988
Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease
B Dubois, B Pillon, F Legault, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 1, 1994
Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease
A Michon, B Deweer, B Pillon, et al.
Brain Research
|
March 26, 1993
Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease
A Kastner, E C Hirsch, Y Agid, et al.
Experimental Neurology
|
May 1, 1997
Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease
F Boissiere, B Faucheux, M Ruberg, et al.
Lancet (London, England)
|
August 25, 1999
Blood vessels change in the mesencephalon of patients with Parkinson's disease
B A Faucheux, A M Bonnet, Y Agid, et al.
Brain Research
|
December 12, 1983
A subcortico-cortical cholinergic system is affected in Parkinson's disease
B Dubois, M Ruberg, F Javoy-Agid, et al.
Neurology
|
October 1, 1995
Levodopa-induced dyskinesias are improved by fluoxetine
F Durif, M Vidailhet, A M Bonnet, et al.
Journal of Inherited Metabolic Disease
|
June 20, 2008
Movement disorders and inborn errors of metabolism in adults: a diagnostic approach
F Sedel, J-M Saudubray, E Roze, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 1, 1995
A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine
A M Bonnet, I Serre, R Marconi, et al.
Page
of 62
Search research articles
Search
Showing results (131-140 of 611) with videos related to
Sort By:
Page
of 62
Neuroscience Letters
|
February 25, 1991
Cholinergic neuronal loss in the globus pallidus of Alzheimer disease patients
S Lehéricy, E C Hirsch, L B Hersh, et al.
Archives of Neurology
|
November 1, 1988
Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease
B Dubois, B Pillon, F Legault, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 1, 1994
Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease
A Michon, B Deweer, B Pillon, et al.
Brain Research
|
March 26, 1993
Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease
A Kastner, E C Hirsch, Y Agid, et al.
Experimental Neurology
|
May 1, 1997
Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease
F Boissiere, B Faucheux, M Ruberg, et al.
Lancet (London, England)
|
August 25, 1999
Blood vessels change in the mesencephalon of patients with Parkinson's disease
B A Faucheux, A M Bonnet, Y Agid, et al.
Brain Research
|
December 12, 1983
A subcortico-cortical cholinergic system is affected in Parkinson's disease
B Dubois, M Ruberg, F Javoy-Agid, et al.
Neurology
|
October 1, 1995
Levodopa-induced dyskinesias are improved by fluoxetine
F Durif, M Vidailhet, A M Bonnet, et al.
Journal of Inherited Metabolic Disease
|
June 20, 2008
Movement disorders and inborn errors of metabolism in adults: a diagnostic approach
F Sedel, J-M Saudubray, E Roze, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 1, 1995
A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine
A M Bonnet, I Serre, R Marconi, et al.
Page
of 62